|
RAD51C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.02570174576044E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.49810213918067E-11 |
| Normal-vs-Stage2 |
1.723810E-03 |
| Normal-vs-Stage3 |
4.44060010984515E-10 |
| Normal-vs-Stage4 |
1.63191682389652E-12 |
| Stage1-vs-Stage2 |
2.915000E-01 |
| Stage1-vs-Stage3 |
2.229600E-01 |
| Stage1-vs-Stage4 |
5.822700E-04 |
| Stage2-vs-Stage3 |
1.077430E-01 |
| Stage2-vs-Stage4 |
1.844360E-03 |
| Stage3-vs-Stage4 |
1.935610E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.01030303514926E-11 |
| Normal-vs-AfricanAmerican |
4.33289999990372E-07 |
| Normal-vs-Asian |
1.90950000256151E-09 |
| Caucasian-vs-AfricanAmerican |
4.945400E-01 |
| Caucasian-vs-Asian |
2.923400E-01 |
| AfricanAmerican-vs-Asian |
9.224600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.0627054791712E-12 |
| Normal-vs-Female |
3.46080053503783E-10 |
| Male-vs-Female |
6.791800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.31660254815347E-11 |
| Normal-vs-Age(41-60Yrs) |
1.90130022836854E-10 |
| Normal-vs-Age(61-80Yrs) |
1.3946999999348E-08 |
| Normal-vs-Age(81-100Yrs) |
6.580600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.596600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.611400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.131800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.755200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.481200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.343000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.780400E-01 |
| Classical-VS-Follicular |
5.878300E-02 |
| Classical-VS-Other |
9.889400E-01 |
| Classical-VS-Normal |
1.94377847151372E-12 |
| Tall-VS-Follicular |
5.385900E-02 |
| Tall-VS-Other |
7.240400E-01 |
| Tall-VS-Normal |
3.90309999875882E-08 |
| Follicular-VS-Other |
5.636400E-01 |
| Follicular-VS-Normal |
7.55399999999851E-05 |
| Other-VS-Normal |
4.099500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.0509000294503E-10 |
| Normal-vs-N1 |
6.16029449673761E-11 |
| N0-vs-N1 |
2.938200E-02 |
|
|
